Effect of Breather in COPD Patients With Intermittent Claudication

NCT06529185 · tracked via the Priya Life Science Egypt tracker

Sponsor

Cairo University

Phase

Not applicable

Started

2024-07-30

Last updated

2024-12-31

Condition(s) studied

COPDPAD

Investigational drug(s) / intervention(s)

The BREATHERpharmacological treatment

The BREATHER: The BREATHER is Light/Medium resistance inspiratory muscle trainer which has significance role in increasing inspiratory muscle strength and endurance which could result in a decreased sensation of dyspnea

pharmacological treatment: patient will receive the usually pharmacological treatment.

Study summary

The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.

Eligibility

Sex

MALE

Min age

50 Years

Max age

60 Years

Healthy volunteers

Inclusion Criteria: * sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years * All patients will be clinically and medically stable when attending the study. * Body mass index (BMI) is 18.5 to 24.9 kg/m2. * History of unilateral exertional leg pain, * Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad), * And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise. Exclusion Criteria: * cardiovascular insufficiency, * Recent myocardial infarction, * heart failure, * arrhythmia, * DVT, * Intracranial hypertension, * Pneumonia, * kidney failure, * fractures, * uncooperative patients, * cognitive impairment preventing a patient from participation in exercises.

Primary outcome measure(s)

Ventilatory function: by spirometry test — 4 weeks
Spirometry is a physiological test that measures the ability to inhale and exhale air relative to time.
Vascular function: by doppler ultrasound — 4 weeks
Doppler ultrasound is a simple and non-invasive and method for the evaluation of early atherosclerosis. It can be used as a screening program for PAD in populations with high risk for atherosclerosis.

Trial sites (1)

Facility	City	Region	Status
Faculty of Physical Therapy	Dokki	Egypt	Recruiting

More Cairo University trials in Egypt

Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity Enrolling by invitation

Clinical and Radiographic Evaluation of Calcium Hypochlorite Versus Saline As Root Canal Irrigants in Pulpectomy of Primary Molars: a Randomized Clinical Trial Starting soon

Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis Starting soon

Music Effect on Concentration and Gait in Cerebral Palsy Children During Physical Therapy Sessions Starting soon

Clinical and Radiographic Evaluation of Immediate Implant Placement Using Osseodensification Versus Traditional Drilling Protocol Recruiting

Other trials for the same condition

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases Recruiting

Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial Recruiting

High-Flow Nasal Cannula Versus Noninvasive Ventilation After Extubation in Patients With COPD and Mild Hypercapnic Respiratory Failure Active, not recruiting

"The Effect of Inhaled Nitroglycerin for COPD Patients Recruiting

Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06529185 on ClinicalTrials.gov ↗ ← All trials in Egypt